Dysthymia: When Depression Becomes Your Baseline

Most people understand depression as something that arrives and, with treatment, eventually lifts. Persistent depressive disorder does not work that way.

Dysthymia, as it was known before the DSM-5 renamed it in 2013, is a form of chronic depression that settles in and stays. The symptoms are often milder than a major depressive episode. But the duration, two years or longer in adults, is what makes it so damaging. You adapt to the weight. You stop comparing your mood to what feeling well would actually feel like. You start describing yourself as someone who is just not a happy person.

That is not a personality trait. It is a treatable medical condition.

What This Page Covers

• How PDD differs from major depression
• The diagnostic criteria and what they mean clinically
• Why so many people go undiagnosed for years
• Double depression: when MDE layers on top of PDD
• What treatment actually produces results
• How SiggyMD supports people managing chronic depression

What Persistent Depressive Disorder Actually Is

In 2013, the DSM-5 consolidated two older diagnoses, dysthymic disorder and chronic major depressive disorder, into a single category: Persistent Depressive Disorder (PDD), defined by a depressed mood that occurs for most of the day, for more days than not, for at least two years.

The change reflected decades of clinical evidence showing that the distinction between chronic low-grade depression and chronic major depression was less meaningful in practice than the shared features of chronicity, functional impairment, and treatment complexity.

An estimated 1.5% of U.S. adults have persistent depressive disorder in any given year, though this is likely an undercount given how rarely people with mild chronic depressive symptoms seek evaluation.

The essential diagnostic requirement is a depressed mood on most days, most of the day, for two years (one year in children and adolescents). At least two of the following symptoms must also be present: poor appetite or overeating, insomnia or hypersomnia, fatigue or low energy, low self-esteem, poor concentration or difficulty making decisions, and hopelessness. During the two-year period, the person must not have been symptom-free for more than two months at a stretch.

How PDD Differs from Major Depression

The core difference is duration over severity. Major depressive disorder (MDD) is episodic: symptoms meet a higher threshold but typically occur in discrete episodes. PDD is defined by its persistence. Symptoms may be less severe than a major depressive episode but are continuous, often spanning years or decades.

This matters clinically for a few reasons.

PDD is often associated with adverse prognostic indicators, including high rates of comorbidity, impairment, and earlier onset than episodic depression. It also responds somewhat differently to treatment: research suggests that pharmacological and psychotherapeutic interventions may be less effective for chronic forms of depression, particularly dysthymia, than for non-chronic depressive disorders. This is not because treatment doesn’t work. It is because longer duration, earlier onset, and cumulative functional impairment create a more complex clinical picture.

There are also differences in how the person experiences it. Someone in a major depressive episode typically has a recognizable before: a time when they felt better. People with early-onset PDD often have no such reference point. Individuals with PDD may perceive their depressed mood as a character or personality trait rather than a distinct medical condition and never discuss their symptoms with a healthcare provider.

Why Dysthymia Goes Undiagnosed

Three patterns explain most missed diagnoses.

Normalization. When symptoms have been present since adolescence or young adulthood, they become the baseline. Low energy, mild hopelessness, difficulty finding pleasure, and a persistent undercurrent of sadness feel like personality rather than illness. The diagnostic conversation never happens because nothing seems dramatically wrong.

Severity mismatch. Both patients and clinicians who expect depression to look like severe functional impairment can miss PDD. The person is functioning. They are going to work. They are not in crisis. But persistent low-grade depression can lead to significant functional impairment if untreated. The cumulative effect of years of mild-to-moderate impairment often exceeds the impact of a single severe episode.

Double depression confusion. When a major depressive episode develops on top of PDD, the MDE becomes the clinical focus. Treatment addresses the acute episode. When it remits, the person appears to recover. The underlying chronic condition remains unaddressed, and the cycle repeats.

Double Depression: A Well-Documented Complication

Double depression is the clinical term for the occurrence of a major depressive episode superimposed on pre-existing PDD. A meta-analysis of 11 studies including 775 patients found that a higher proportion of individuals with double depression within a sample was associated with lower effect sizes for pharmacotherapy, suggesting double depression may be more difficult to treat than either MDD or dysthymia alone.

The pattern is clinically significant for two reasons. First, when the MDE lifts, the person does not fully recover. They return to their PDD baseline, which often feels like recovery only because the acute episode was so much worse. Second, untreated PDD substantially increases the risk of future major depressive episodes.

For clinicians, this means that apparent recovery from a major depressive episode requires investigation. If depressive symptoms persist at a lower level after the acute phase, a PDD diagnosis should be considered and treated accordingly.

What the Research Shows About Treatment

Medication

A systematic review and meta-analysis found that SSRIs, TCAs, and MAOIs are all effective for dysthymia, with SSRIs showing a mean response rate of approximately 55% compared to 31% for placebo. SSRIs are preferred as first-line due to tolerability. SNRIs, bupropion, and mirtazapine are alternatives for non-response.

For treatment-resistant PDD, augmentation strategies include lithium, thyroid hormone supplementation, and low-dose amisulpride. These approaches are typically managed by a psychiatrist in consultation.

One important consideration: antidepressants take 4 to 6 weeks to show full effect, and PDD often requires longer medication trials than episodic depression. Stopping medication too early is a common cause of apparent treatment failure.

Psychotherapy

CBT and interpersonal therapy (IPT) are both supported for PDD. For people with early-onset or trauma-related chronic depression, CBASP, the Cognitive Behavioral Analysis System of Psychotherapy, was specifically developed for chronic depression and shows particular promise.

Standard CBT focuses on activity scheduling, problem-solving, and challenging negative automatic thoughts. For PDD, CBT should be structured, skills-focused, and explicitly targeted at the chronic course, not adapted from protocols designed for episodic depression.

Combination Treatment

Medication and psychotherapy used in combination result in higher response rates and improved functioning for PDD than either alone. This is consistent with evidence across depression subtypes: the two treatments work through complementary mechanisms. Medication reduces symptom burden and improves capacity to engage in therapy. Therapy addresses the cognitive patterns and behavioral habits that maintain chronic depression.

Studies of patients with chronic depression have shown better outcomes with longer duration of psychotherapy and higher numbers of sessions. Short-course therapy alone tends to show weaker results for PDD than for episodic MDD. Expect treatment to take longer, not because recovery is impossible, but because the condition is more complex.

The Early-Onset Pattern

PDD has two course specifiers based on age: early onset (before age 21) and late onset (age 21 or later). Early-onset PDD is associated with a more complex clinical picture, including higher rates of adverse childhood experiences, greater comorbidity with personality disorders and anxiety, and poorer response to medication alone.

For people with early-onset PDD, targeted psychotherapy addressing trauma history, interpersonal patterns, and the developmental impact of chronic depression is often a necessary part of treatment. The CBASP model was designed with this population in mind.

About SiggyMD

Persistent depressive disorder is a chronic condition. It improves most durably with consistent, ongoing clinical oversight, not with a single prescription refilled until something changes.

SiggyMD provides clinician-supervised medication management with daily monitoring between appointments. For people managing PDD, that means side effects addressed within days rather than months, medication adjustments informed by ongoing check-in data, and a prescriber who can see your progress pattern rather than reconstructing it from memory at a quarterly appointment.

“Dysthymia often gets missed because the person has spent years normalizing a level of functioning that is actually depressed,” says Daniel Montville, MD, Psychiatrist at SiggyMD. “When someone gets an accurate diagnosis and adequate treatment, the change can be striking. The ceiling they thought they had wasn’t the ceiling. It was the illness.”

The anonymous intake at SiggyMD requires no name, email, or account to start. A licensed prescriber reviews every treatment plan.

For people also experiencing major depressive episodes on top of chronic depression, read our post on what depression feels like and major depressive disorder.

Explore the related condition with our guide on what is depression for a broader overview of the depressive disorder spectrum.

Start your anonymous intake with SiggyMD to talk with a licensed prescriber about chronic depression, what a treatment plan would look like, and how ongoing monitoring can change the outcome.

What Members Are Saying

DK

D.K., 38

Persistent Depressive Disorder

“I spent 15 years thinking I just had a low-grade personality. I was fine, I was functional, but I was never really okay. It wasn’t until I read a description of dysthymia that something clicked. When I finally got a diagnosis and started treatment, I realized I had been comparing myself to myself on a bad day rather than to what I could actually feel like. That was genuinely new information.”

ML

M.L., 29

PDD with Double Depression

“I had a bad episode two years ago and got treated for that. But after it lifted, I still felt off, just not as bad. My prescriber at SiggyMD flagged that what was left wasn’t just residual symptoms from the episode. They treated it as a separate ongoing condition. That distinction mattered. I stopped waiting to feel completely better on my own.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. You can begin anonymous intake without an account, name, email, or payment.

If you are experiencing thoughts of self-harm or suicide, call or text 988 to reach the Suicide and Crisis Lifeline. If you are in immediate danger, call 911.

Sources

1. StatPearls. Persistent Depressive Disorder. NCBI Bookshelf. Updated 2024.

2. National Institute of Mental Health. Persistent Depressive Disorder Statistics. NIMH. Accessed June 2026.

3. May DG, Shaffer VN, Yoon KL. Treatment of double depression: A meta-analysis. Psychiatry Research. 2020;291:113262.

4. Inoue T, et al. Dysthymia and Apathy: Diagnosis and Treatment. Depression Research and Treatment. 2011.

5. Suvak MK, et al. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications. Lancet Psychiatry. 2020.

6. Psychiatric Times. Persistent Depressive Disorder, Dysthymia, and Chronic Depression: Update on Diagnosis, Treatment. Accessed June 2026.

7. APA Focus. Dysthymic Disorder and Other Chronic Depressions. Focus. 2012.

8. Johns Hopkins Medicine. Dysthymia. Accessed June 2026.

9. National Institute of Mental Health. Depression Overview. NIMH. Accessed June 2026.